Clinical Trial Update: Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii [Phase 4]

View source ↗

Summary

This update reports on the effectiveness and safety of tigecycline for infections caused by multi-drug resistant Acinetobacter baumannii in a Phase 4 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

Sponsor: Mahidol University | Conditions: Antibiotic Resistant Infection | Phase 4 | Status: UNKNOWN